Róisín Shortall (Dublin North West, Labour)

Many new drugs either above or below these levels are approved, while many others above or below them are rejected. That input from the NCPE is only one of a number of elements taken into consideration in the decision making process to approve a new drug for reimbursement.

See this speech in context